Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Astrocyte Pharmaceuticals has raised $6.0M in total funding. The most recent round was Series B. The last funding was announced in August 2023.
Astrocyte Pharmaceuticals's investors include DeepWork Capital, National Institutes of Health, Navis Capital Partners, Alzheimer's Drug Discovery Foundation, BrightFocus Foundation.
Astrocyte Pharmaceuticals is headquartered in Cambridge, United States.
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Astrocyte Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Astrocyte Pharmaceuticals — Funding & Investors." VCBacked, August 18, 2023, https://www.vcbacked.co/company/astrocyte-pharmaceuticals. Accessed July 20, 2026.
VCBacked. (2023). Astrocyte Pharmaceuticals — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/astrocyte-pharmaceuticals
{{cite web |title=Astrocyte Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/astrocyte-pharmaceuticals |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated